Company Filing History:
Years Active: 2017-2019
Title: Heiko Pultke: Innovator in Biotech
Introduction
Heiko Pultke is a notable inventor based in Halle/Saale, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of proNGF mutants for medical applications. His work has led to advancements in the production of biologically active human beta-NGF.
Latest Patents
Heiko Pultke holds 2 patents. His latest patents focus on proNGF mutants and their uses in the production of beta-NGF. The inventions disclose methods for preparing biologically active human beta-NGF from inactive insoluble proNGF mutants. These proNGF mutants are characterized by substitutions at the native protease cleavage site, specifically avoiding Arg or Lys at critical positions.
Career Highlights
Heiko Pultke is associated with Wacker Chemie AG, a leading company in the chemical industry. His work at the company has been instrumental in advancing research and development in biotechnology. He has been recognized for his innovative approaches and contributions to the field.
Collaborations
Heiko has collaborated with notable coworkers, including Susan Lorey and Bernhard Janowski. Their teamwork has fostered a productive environment for innovation and research.
Conclusion
Heiko Pultke's contributions to biotechnology, particularly through his patents on proNGF mutants, highlight his role as a significant inventor in the field. His work continues to influence advancements in medical applications.